Induction of TRAIL-mediated glioma cell death by human T cells

被引:22
作者
Dörr, J [1 ]
Waiczies, S [1 ]
Wendling, U [1 ]
Seeger, B [1 ]
Zipp, F [1 ]
机构
[1] Ctr Res Neurosci, Dept Neurol, Div Neuroimmunol, D-10098 Berlin, Germany
关键词
TRAIL; T cell; apoptosis; cytotoxicity; glioma;
D O I
10.1016/S0165-5728(01)00450-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among the death ligands of the tumor necrosis factor/nerve growth factor (TNF/NGF) superfamily, TNF-related apoptosis-inducing ligand (TRAIL) is considered to play a unique role due to its binding to both apoptosis-inducing and -blocking membranous receptors, apoptosis-independent effects and distinct species differences. Here, we demonstrate that human antigen-specific T helper cells upon activation are capable of directly lysing glioma cell lines via TRAIL receptor/TRAIL interactions. Out of 17 T cell lines, nine showed predominantly TRAIL-mediated killing of glioma cell lines compared to CD95 ligand- or TNF-induced cell death. The cytotoxic potential of the T cell lines was independent of T helper differentiation, antigen specificity and donor source. Thus, TRAIL-mediated signaling is involved in T cell cytotoxicity towards glioma cell lines, which might play an important role in tumor regression. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:117 / 124
页数:8
相关论文
共 39 条
[1]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[2]  
BODMER S, 1989, J IMMUNOL, V143, P3222
[3]   Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease [J].
Braun, MY ;
Lowin, B ;
French, L ;
AchaOrbea, H ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :657-661
[4]   DEPRESSED CELL-MEDIATED IMMUNITY IN PATIENTS WITH PRIMARY INTRACRANIAL TUMORS - CHARACTERIZATION OF A HUMORAL IMMUNOSUPPRESSIVE FACTOR [J].
BROOKS, WH ;
NETSKY, MG ;
NORMANSELL, DE ;
HORWITZ, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (06) :1631-+
[5]   MALIGNANT GLIOMA MODULATION OF IMMUNE FUNCTION - RELATIVE CONTRIBUTION OF DIFFERENT SOLUBLE FACTORS [J].
COULDWELL, WT ;
DOREDUFFY, P ;
APUZZO, MLJ ;
ANTEL, JP .
JOURNAL OF NEUROIMMUNOLOGY, 1991, 33 (02) :89-96
[6]   The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain [J].
Degli-Esposti, MA ;
Dougall, WC ;
Smolak, PJ ;
Waugh, JY ;
Smith, CA ;
Goodwin, RG .
IMMUNITY, 1997, 7 (06) :813-820
[7]   Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family [J].
DegliEsposti, MA ;
Smolak, PJ ;
Walczak, H ;
Waugh, J ;
Huang, CP ;
DuBose, RF ;
Goodwin, RG ;
Smith, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1165-1170
[8]  
ELLIOTT LH, 1984, J IMMUNOL, V132, P1208
[9]   ACTIVATION OF IMMUNOREGULATORY LYMPHOCYTES OBTAINED FROM PATIENTS WITH MALIGNANT GLIOMAS [J].
ELLIOTT, LH ;
BROOKS, WH ;
ROSZMAN, TL .
JOURNAL OF NEUROSURGERY, 1987, 67 (02) :231-236
[10]  
Eylar E H, 1974, Methods Enzymol, V32, P323